Naturalistic-observational studies in the framework of ADHD health care

European Child and Adolescent Psychiatry

Volumn 15, Issue SUPPL. 1, 2006, Pages

  Rothenberger, A ^a   Coghill, D ^b   Dopfner M ^c   Falissard, B ^d   Steinhausen, H C ^e  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c UNIVERSITY OF COLOGNE   (Germany)

^d Universite Paris Sud   (France)

^e UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ATTENTION DEFICIT DISORDER; CHILD; CIGARETTE SMOKING; CLINICAL PRACTICE; CLINICAL STUDY; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EDITORIAL; HUMAN; MEDICAL RESEARCH; MENTAL HEALTH CARE; OPPOSITIONAL DEFIANT DISORDER; PRACTICE GUIDELINE; QUALITY OF LIFE; RATING SCALE; SOCIAL PSYCHOLOGY;

EID: 33845735918     PISSN: 10188827     EISSN: 1435165X     Source Type: Journal    
DOI: 10.1007/s00787-006-1001-1     Document Type: Editorial

References (21)

1. Andersen M, Kragstrup J, Sondergaard J (2006) How conducting a clinical trial affects physicians' guideline adherence and drug preferences. Journal of the Am Med Assoc 295:2759-2764
2. Banaschewski T, Coghill D, Santosh P, Zuddas A, Ascherson P, Buitelaar J, Danckaerts M, Döpfner M, Faraone SV, Rothenberger A, Sergeant J, Steinhausen HC, Sonuga-Barke EJ, Taylor E (2006) Long-acting medications for the hyperkinetic disorders: A systematic review and European guideline. Eur Child Adolesc Psychiatry (in press)
3. Becker A, Steinhausen HC, Baldursson G, Dalsgaard S, Lorenzo MJ, Ralston SJ, Döpfner M, Rothenberger A and the ADORE study group (2006) Psychopathological screening of children with ADHD: Strengths and Difficulties Questionnaire in a pan-European study. Eur Child Adolesc Psychiatry 15(Suppl 1):56-62
4. Coghill D, Spiel G, Baldursson G, Döpfner M, Lorenzo MJ, Ralston S, Rothenberger A and the ADORE study group (2006) Which factors impact on clinician-rated impairment in children with ADHD? Eur Child Adolesc Psychiatry 15(Suppl 1):30-37
5. Döpfner M, Breuer D, Schürmann S, Wolff Metternich T, Rademacher C, Lehmkuhl G (2004) Effectiveness of an adaptive multimodal treatment in children with Attention Deficit Hyperactivity Disorder - global outcome. European Child and Adolescent Psychiatry 13(Suppl 1):117-129
6. Döpfner M, Steinhausen HC, Coghill D, Dalsgaard S, Poole L, Ralston SJ, Rothenberger A and the ADORE study group (2006) Cross-cultural reliability and validity of ADHD assessed by the ADHD Rating Scale in a pan-European study. Eur Child Adolesc Psychiatry 15(Suppl 1):46-55
7. Meyer R (2006) Anwendungsbeobachtungen - Verführerisches Marketing-instrument. (Observational studies - a seductive marketing instrument). Deutsches Ärzteblatt 103(26):B1529
8. MTA Study Group (1999) A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 56:1073-1086
9. MTA Study Group (2004) National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. Pediatrics 113:754-761
10. MTA Study Group (2004) National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics 113:762-769
11. Nøvik TS, Hervas A, Ralston SJ, Dalsgaard S, Pereira RR, Lorenzo MJ and the ADORE study group. Influence of gender on Attention-Deficit/ Hyperactivity Disorder in Europe - ADORE. Eur Child Adolesc Psychiatry 15(Suppl 1):15-24
12. Pine DS (2005) Editorial: Where have all the clinical trials gone. J Child Psychol Psychiatry 46:449-450
13. Preuss U, Ralston SJ, Baldursson G, Falissard B, Lorenzo MJ, Pereira RR, Valsveld L, Coghill D and the ADORE study group (2006) Study design, baseline characteristics and interventions in a cross-cultural framework: results from the ADORE study. Eur Child Adolesc Psychiatry 15(Suppl 1):4-13
14. Ralston SJ, Lorenzo MJ, ADORE Study Group (2004) ADORE-Attention-Deficit Hyperactivity Disorder Observational Research in Europe. Eur Child Adoles Psychiatry 13(Suppl 1):36-42
15. Riley AW, Coghill D, Forrest CB, Lorenzo MJ, Ralston SJ, Spiel G and the ADORE study group (2006) Validity of the health-related quality of life assessment in the ADORE study: Parent Report Form of the CHIP-Child Edition. Eur J Child Adolescent Psychiatry 15(Suppl 1):63-71
16. Riley AW, Lyman LM, Spiel G, Döpfner M, Lorenzo MJ, Ralston SJ and the ADORE study group (2006) The Family Strain Index (FSI). Reliability, validity and factor structure of a brief questionnaire for families of children with ADHD. Eur Child Adolesc Psychiatry 15(Suppl 1):72-78
17. Riley AW, Spiel G, Coghill D, Döpfner M, Falissard B, Lorenzo MJ, Preuss U, Ralston SJ and the ADORE study group. Factors related to Health-Related Quality of Life (HRQoL) among children with ADHD in Europe at entry into treatment. Eur Child Adolesc Psychiatry 15(Suppl 1):38-45
18. Steinhausen HC, Nøvick TS, Baldursson G, Curatolo P, Lorenzo MJ, Pereira RR, Ralston SJ, Rothenberger A and the ADORE study group (2006) Co-existing psychiatric problems in ADHD in the ADORE cohort. Eur Child Adolesc Psychiatry 15(Suppl 1):25-29
19. Taylor E, Döpfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Rothenberger A, Sonuga-Barke E, Steinhausen HC, Zuddas A (2004) European clinical guidelines for hyperkinetic disorder - first upgrade. Eur Child Adolesc Psychiatry 13(Suppl 1):7-30
20. Taylor E, Sergeant J, Döpfner M, Gunning B, Overmeyer S, Möbius HJ, Eissert HG (1998) Clinical Guidelines for hyperkinetic disorder. Eur Child Adolesc Psychiatry 54:329-336
21. Willich SN (2006) Randomisierte kontrollierte Studien: Pragmatische Ansätze erforderlich. (Randomized controlled trials - pragmatic approaches required). Deutsches Ärzteblatt 103(39):B2185-B2189